Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανάπτυξη και αξιολόγηση ραδιοεπισημασμένων συνθετικών αναλόγων της σωματοστατίνης για την in vivo εντόπιση νεοπλασμάτων

Abstract

dc:description

The overexpression of somatostatin receptor subtype 2 (sst2) in many neoplasms of mainly neuroendocrine origin has resulted in an established method for the in vivo diagnostic imaging of sst2-positive tumors using OctreoScan® ([111Ιn-DTPA0]octreotide). Despite its initial success, OctreoScan®’s broader application is hampered by using 111In. Given that, 99mTc still remains the ideal diagnostic radionuclide of nuclear medicine due to important practical and financial advantages the development of a specific sst2-seeking [99mTc]-radiotracer as an alternative to OctreoScan® is highly attractive. In the present thesis, the synthesis and the biological evaluation of two novel somatostatin peptide analogs, functionalized at the N-terminus with an acyclic tetraamine chelator for effective 99mTc binding: Demotide ([Ν40,Tyr3]octreotide) and Demotate ([Ν40,Tyr3]octreotate) differing only at the C-terminus (Thr(ol)8 versus Thr8-OH, respectively), is described. Synthesis of Demotide was performed in solution whereas Demotate was synthesized on the solid support. Identification of new analogs comprised ESI-MS and RP-HPLC. Their binding affinity for sst2 was determined by competition binding experiments in sst2-positive rat brain cortex or AR4-2J and CA20948 cell membranes. Their hsst1-5 binding profile was determined by in vitro receptor autoradiography. Labeling with 99mTc led to [99mTc]Demotide and [99mTc]Demotate. The radiopeptide affinity for the sst2 was determined by saturation binding assays in AR4-2J membranes and their internalization was tested in AR4-2J cells. Biodistribution was studied in healthy (Swiss albino mice and Wistar rats) and pathological animal models (AR4-2J tumor-bearing Swiss nu/nu mice and CA20948 tumor-bearing Lewis rats). In conclusion, [99mTc]Demotide and [99mTc]Demotate satisfied important criteria and combined a variety of favorable properties for successful application in the targeted diagnostic imaging of sst2-positive tumors in man, such as favorable pharmacokinetics, metabolic stability as well as rapid and high in vivo sst2-targeting. These characteristics provide the prospect to implement a logistically convenient one-day clinical protocol (99mTc: t½= 6.02 h) without compromising image quality. Such a protocol will facilitate the patient management in clinical practice in comparison to OctreoScan® (111In: t½= 67.2 h). The latter is more suitable for a two-day examination protocol according to the manufacturer’s suggestion. Further studies are expected to confirm their potential diagnostic value in the clinic.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Nikolopoulou, Anastasia
  • Νικολοπούλου, Αναστασία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/15902

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Nikolopoulou, Anastasia; Νικολοπούλου, Αναστασία. Ανάπτυξη και αξιολόγηση ραδιοεπισημασμένων συνθετικών αναλόγων της σωματοστατίνης για την in vivo εντόπιση νεοπλασμάτων. Aristotle University Of Thessaloniki (AUTH), 2008. http://hdl.handle.net/10442/hedi/15902